HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction
Clinical trial NCT06391710 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06391710
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-06
- Primary completion
- 2026-01-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.